For example, the OASIS-4 trial showed an average weight loss of 13.6% with the maximum 25 mg dose, which takes 4 months to reach under the licensed dosing protocol
The first large clinical trial was carried out David Rudd research group as an international, multicenter trial with three treatment schemes (200, 400, and 600 mg/day) [165]
Like many medications that affect the gastrointestinal system, tirzepatide can cause side effects, especially when starting treatment or increasing dosage
According to a study on glutathione pathways in the brain, glutathione is the main factor in cellular detoxification of brain cells, and it has both intracellular and extracellular functions in the brain
A meta-analysis reports that orforglipron had a faster onset (6.4 weeks) than tirzepatide (19.5 weeks)